A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

All these years I thought that thin people — those people — just had more willpower,” Winfrey said on her podcast.

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

However, a recent study from Johns Hopkins University offers new hope. Researchers found that an experimental drug, ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

In the world of weight loss supplements, the quest for effective products that truly deliver results has led many to explore ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

That's what a new study, which found that drinking elderberry juice daily may boost weight loss, suggests. It also reportedly ...

The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...